|Bid||10.83 x 1400|
|Ask||10.87 x 1200|
|Day's range||10.61 - 11.20|
|52-week range||8.75 - 95.34|
|Beta (5Y monthly)||1.75|
|PE ratio (TTM)||N/A|
|Earnings date||27 Feb 2023 - 03 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||55.33|
Novavax (NVAX) closed the most recent trading day at $11.09, moving -1.25% from the previous trading session.
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.